Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 9 | 2024 | 144 | 3.810 |
Why?
|
| Neuroblastoma | 7 | 2012 | 395 | 0.850 |
Why?
|
| Lead Poisoning | 1 | 2018 | 10 | 0.610 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2015 | 6 | 0.510 |
Why?
|
| Quality of Life | 1 | 2024 | 1668 | 0.510 |
Why?
|
| Uterine Hemorrhage | 1 | 2015 | 21 | 0.510 |
Why?
|
| Stroke | 1 | 2024 | 986 | 0.480 |
Why?
|
| Fever | 1 | 2015 | 128 | 0.480 |
Why?
|
| Ambulatory Care | 1 | 2015 | 187 | 0.460 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 247 | 0.370 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2010 | 18 | 0.370 |
Why?
|
| Adherens Junctions | 2 | 2021 | 34 | 0.360 |
Why?
|
| Low Back Pain | 1 | 2010 | 41 | 0.360 |
Why?
|
| Child, Preschool | 5 | 2024 | 3731 | 0.360 |
Why?
|
| Neovascularization, Pathologic | 4 | 2011 | 364 | 0.350 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2010 | 81 | 0.350 |
Why?
|
| Endothelial Cells | 4 | 2021 | 460 | 0.340 |
Why?
|
| Acute Chest Syndrome | 2 | 2020 | 16 | 0.320 |
Why?
|
| Child | 6 | 2024 | 7174 | 0.290 |
Why?
|
| Food Assistance | 1 | 2024 | 8 | 0.240 |
Why?
|
| Fetal Hemoglobin | 1 | 2023 | 14 | 0.230 |
Why?
|
| Hydroxyurea | 1 | 2024 | 239 | 0.220 |
Why?
|
| Immunization | 1 | 2024 | 160 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2012 | 1652 | 0.220 |
Why?
|
| Blood Transfusion | 1 | 2024 | 169 | 0.210 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 78 | 0.210 |
Why?
|
| Extracellular Vesicles | 2 | 2021 | 42 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2023 | 254 | 0.210 |
Why?
|
| Humans | 15 | 2024 | 89357 | 0.200 |
Why?
|
| Adolescent | 5 | 2024 | 9263 | 0.190 |
Why?
|
| Female | 10 | 2024 | 46202 | 0.170 |
Why?
|
| Osteonectin | 2 | 2010 | 22 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2011 | 317 | 0.160 |
Why?
|
| Young Adult | 3 | 2024 | 6312 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 890 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 53 | 0.140 |
Why?
|
| Male | 7 | 2024 | 42411 | 0.130 |
Why?
|
| Blood | 1 | 2015 | 69 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2009 | 755 | 0.120 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 60 | 0.100 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 66 | 0.100 |
Why?
|
| Mice, Nude | 5 | 2012 | 815 | 0.100 |
Why?
|
| Stromal Cells | 2 | 2009 | 151 | 0.090 |
Why?
|
| Flank Pain | 1 | 2010 | 5 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 198 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1597 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3448 | 0.090 |
Why?
|
| Pruritus | 1 | 2010 | 29 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2011 | 50 | 0.090 |
Why?
|
| Infant | 2 | 2015 | 3160 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 323 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 106 | 0.090 |
Why?
|
| Cadherins | 2 | 2021 | 163 | 0.090 |
Why?
|
| Creatinine | 1 | 2010 | 293 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 788 | 0.090 |
Why?
|
| Pyridines | 1 | 2011 | 315 | 0.080 |
Why?
|
| Schwann Cells | 1 | 2009 | 34 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2012 | 2558 | 0.080 |
Why?
|
| Antineoplastic Agents | 4 | 2012 | 2415 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2012 | 657 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 605 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5499 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 127 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 1265 | 0.070 |
Why?
|
| Adult | 2 | 2024 | 26607 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 5338 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1525 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2012 | 470 | 0.060 |
Why?
|
| Mice | 6 | 2023 | 11761 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2015 | 8241 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 860 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 2566 | 0.060 |
Why?
|
| Hemoglobin, Sickle | 1 | 2023 | 19 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2884 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2023 | 159 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1799 | 0.050 |
Why?
|
| Actins | 2 | 2020 | 458 | 0.050 |
Why?
|
| Heme | 1 | 2020 | 64 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2661 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 956 | 0.040 |
Why?
|
| Microcirculation | 1 | 2020 | 104 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 397 | 0.040 |
Why?
|
| Animals | 6 | 2023 | 27371 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2011 | 509 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2020 | 164 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 466 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 433 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 89 | 0.040 |
Why?
|
| Risk | 1 | 2017 | 657 | 0.030 |
Why?
|
| Cell Movement | 2 | 2010 | 784 | 0.030 |
Why?
|
| Tretinoin | 1 | 2012 | 128 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1714 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 117 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 274 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 115 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2872 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 299 | 0.020 |
Why?
|
| Pericytes | 1 | 2009 | 13 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 34 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 618 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 507 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 57 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 110 | 0.020 |
Why?
|
| Peptides | 1 | 2010 | 648 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 1109 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 1489 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1057 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 911 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 1767 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2366 | 0.010 |
Why?
|